From: Paradoxical role of hepatocyte growth factor in ischemic stroke: stroke risk/stroke recovery
The patient group | t-test | P value | ||
---|---|---|---|---|
Atherothrombotic (N = 50) | Cardioembolic (N = 50) | |||
HGF Conc. (ng/ml) | ||||
X ± SD | 0.62 ± 0.19 | 0.41 ± 0.09 | 6.88 | < 0.001* |
Range | 0.17–0.85 | 0.15–0.50 |